1986
DOI: 10.1016/0013-4694(86)90189-6
|View full text |Cite
|
Sign up to set email alerts
|

Parkinson disease: Electrophysiological (CNV) analysis related to pharmacological treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
33
0
1

Year Published

1995
1995
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 55 publications
(35 citation statements)
references
References 9 publications
1
33
0
1
Order By: Relevance
“…The CNV amplitude is decreased in PD patients (Amabile et al, 1986;Praamstra et al, 1996;Ikeda et al, 1997). These findings are consistent with involvement of BG in the preparation of an externally triggered movement.…”
Section: Involvement Of the Stn In The Preparation Of Externally Trigsupporting
confidence: 84%
See 2 more Smart Citations
“…The CNV amplitude is decreased in PD patients (Amabile et al, 1986;Praamstra et al, 1996;Ikeda et al, 1997). These findings are consistent with involvement of BG in the preparation of an externally triggered movement.…”
Section: Involvement Of the Stn In The Preparation Of Externally Trigsupporting
confidence: 84%
“…CNV amplitude (Amabile et al, 1986;Pulvermuller et al, 1996;Ikeda et al, 1997) is decreased in PD. Both BP and CNV amplitude have been reported to improve with dopaminergic medications (Amabile et al, 1986;Dick et al, 1987;Jahanshahi et al, 1995;Oishi et al, 1995). However, the CNV is more clearly affected in PD than the BP Berardelli et al, 2001).…”
Section: Implications For Pdmentioning
confidence: 92%
See 1 more Smart Citation
“…This distribution supports earlier hypotheses about a reduction of the CNV amplitude in Parkinson's disease patients. Amabile et al (1986) and Wright et al (1993) found such a reduction, which they attributed to an impaired activation of the SMA. This view is supported by an effect of L-dopa on the CNV amplitude (Amabile et al, 1986) and on the restitution of SMA activity indicated by regional cerebral blood flow measured with PET after dopaminergic medication (Jenkins et al, 1992;Rascol et al, 1994).…”
Section: Movement-related Potentials and Externally Cued Versus Intermentioning
confidence: 92%
“…Amabile et al (1986) and Wright et al (1993) found such a reduction, which they attributed to an impaired activation of the SMA. This view is supported by an effect of L-dopa on the CNV amplitude (Amabile et al, 1986) and on the restitution of SMA activity indicated by regional cerebral blood flow measured with PET after dopaminergic medication (Jenkins et al, 1992;Rascol et al, 1994). Further evidence for an SMA contribution to the CNV comes from magnetoencephalographic studies (Ioannides et al, 1994) and a combined magnetoencephalographic and PET study (Stephan et al, 1995ft).…”
Section: Movement-related Potentials and Externally Cued Versus Intermentioning
confidence: 92%